Category Archives for Newly Diagnosed
Multiple Myeloma Patients are ALL “Toxicity-Vulnerable”
Are you a “Toxicity-Vulnerable” Multiple Myeloma Patient?” It isn’t just old people who are “vulnerable to chemotherapy toxicity.” Everyone suffers collateral damage
Continue readingCancer Prehabilitation-
Cancer prehabilitation is emerging as a method of better preparing patients for the often toxic and disabling effects of cancer treatment. Its place within the continuum of cancer care is rapidly being
Continue readingMultiple Myeloma-More Chemo Is Not Better-
Two concepts have become standard practice in the treatment of multiple myeloma- low-dose maintenance therapy and metronomic therapy. If you click the links and read the info, you will see that the terms
Continue readingMyeloma Diagnosis: What Next?
What Does Being Diagnosed with an “Incurable but Treatable Cancer” Mean for Multiple Myeloma Patients and Survivors? When I was diagnosed in ’94, I had never heard of multiple myeloma
Continue readingChemotherapy-Induced Nerve Pain (CIPN) in Multiple Myeloma
“Chemotherapy-induced peripheral neuropathy (CIPN) may negatively influence multiple myeloma (MM) patients’ health-related quality of life.” While there is a long and growing list of
Continue readingBlogging as Multiple Myeloma Cancer Therapy
A study in the February issue of the Oncologist reports that multiple myeloma patients who engaged in expressive writing just before treatment felt markedly better, mentally and physically I have been
Continue readingMyeloma Cancer Coaching-“Is my oncologist speaking a foreign language?!”
Translate Confusing Multiple Myeloma terms and phrases A diagnosis of multiple myeloma is difficult. The last thing cancer patients and caregivers need is cancer jargon- confusing lingo- from their oncologist.
Continue readingHyperbaric oxygen therapy (HBOT) for Autologous Stem Cell Transplants
“A typical course of hyperbaric oxygen treatments increases by eight-fold the number of stem cells circulating in a patient’s body” Autologus peripheral blood stem cell transplantation (ASCT)
Continue readingFive Steps to Put Multiple Myeloma Patients in Control
Multiple Myeloma Patients and Survivors Must Learn about both Conventional and Non-Conventional Therapies in Order to Manage Their Cancers Successfully Kathy Giusti, fellow long term multiple myeloma survivor
Continue readingMultiple Myeloma + Intravenous Vitamin C
PAA (intravenous vitamin c) selectively kills CD138+MM tumor cells derived from MM and smoldering MM (SMM) Leukemia, lymphoma and multiple myeloma all have a robust collection of FDA approved, standard-of-care
Continue reading